Add like
Add dislike
Add to saved papers

Children in the United States make close to 200,000 emergency department visits due to poisoning each year.

OBJECTIVE: The aim of this study was to provide nationally representative hospital-based emergency department (ED) estimate visits in children (aged ≤ 18 y) attributed to poisoning in the United States in 2008.

METHODS: Nationwide Emergency Department Sample for the year 2008 was used. All ED visits among children (aged ≤ 18 y) with an external cause of injury for "poisoning" were selected for analysis. Demographic characteristics of the ED visits and outcomes examined included ED charges (EDCs), hospitalization charges (HCs), length of stay in hospital, and disposition after ED visit.

RESULTS: During the year 2008, a total of 191,197 ED visits were attributed to poisoning with close to 56% of all ED visits occurring among those aged younger than 4 years. Boys comprised approximately 54% of all ED visits. After an ED visit, 87% were routinely discharged, and 7.3% were admitted into the same hospital. Forty-eight children died in the ED. The frequently reported poisonings included accidental poisoning by other drugs (44,219 ED visits); accidental poisoning by other gases and vapors (27,035 ED visits); and accidental poisoning by analgesics, antipyretics, and antirheumatics (22,334 ED visits). The mean EDC per visit was $1077. The total EDC across the entire United States was $171.8 million. Mean length of stay was 1.9 days. Among those who were hospitalized, the mean HC was $11,792. The total HC across the entire United States was $162.3 million.

CONCLUSIONS: The current study provides nationally representative estimates of ED visits attributed to poisoning among children in the United States. High-risk groups and economics associated with treating these injuries are estimated.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app